tranScrip
A specialist pharmaceutical consultancy providing strategic, therapeutic and operational services across the lifecycle.
A specialist pharmaceutical consultancy providing strategic, therapeutic and operational services across the lifecycle.
tranScrip is a highly specialist pharmaceutical consultancy founded in 2008 in the United Kingdom. The company's slogan "A specialist pharmaceutical consultancy maximising the value of products across the entire lifecycle" encapsulates its mission to provide strategic expertise, therapeutic experience, and operational excellence across the entire product lifecycle. tranScrip's services include building product strategies, designing and executing development programmes, and commercialization activities. The company's team, comprised of experienced physicians, scientists, regulatory, clinical, and commercial experts, offers bespoke solutions and support to maximize the value of products in the Biotechnology, Health Care, and Pharmaceutical industries. Their efforts aim to expedite the development and commercialization of products for the benefit of patients worldwide. In January 27, 2021, tranScrip secured a Private Equity Round investment from Palatine Private Equity. This investment signifies a vote of confidence from the seasoned investors in tranScrip's capabilities in delivering value across the pharmaceutical product lifecycle.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Private Equity Round | Unknown | 1 |
|
27 Jan 2021 |
No recent news or press coverage available for tranScrip.
We care about your data, and we'd love to use cookies make your experience better.
